{"id":"W2947234394","doi":"10.1200/jco.2019.37.15_suppl.1018","title":"In-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Letrozole; Breast cancer; Oncology; Anastrozole; Hazard ratio; Palbociclib; Tamoxifen; Cancer; Progression-free survival; Population; Aromatase inhibitor; Metastatic breast cancer; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001838346,0.0002666469,0.002528148,0.0004323465,0.00002872772,0.000007010192,0.000291013,0.0002299069,0.0002786846],"category_scores_gemma":[0.0001395398,0.0001333265,0.0002747333,0.001015087,0.000217495,0.0003480249,0.00002544335,0.0009019453,9.417576e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002931995,"about_ca_system_score_gemma":0.0009191629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001604815,"about_ca_topic_score_gemma":0.0004311023,"domain_scores_codex":[0.9955834,0.000673539,0.002322862,0.0003443018,0.0007358052,0.0003400847],"domain_scores_gemma":[0.9946257,0.00129087,0.002907455,0.0003760666,0.0006318004,0.0001680645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4416994,0.004370719,0.4722499,0.000009166718,0.00132662,0.0001096826,0.0004892016,0.001354531,0.001856672,0.000002982055,0.000008722303,0.07652238],"study_design_scores_gemma":[0.3261051,0.04393484,0.6268916,0.0002946643,0.0007931337,0.00003056195,0.0004404956,0.00008719533,0.0004971303,0.00001781233,0.0007642864,0.0001432447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969974,0.0004439341,0.00009550263,0.0009984607,0.0001932968,0.001051418,0.00002168623,0.000006616651,0.0001916804],"genre_scores_gemma":[0.9966744,0.0004195472,0.001426829,0.001044953,0.000287044,0.00004911357,0.00001292642,0.00003261819,0.00005256643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1546417,"threshold_uncertainty_score":0.5436898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0537606512115552,"score_gpt":0.4382185384154393,"score_spread":0.3844578872038841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}